WO2002038602A3 - Secreted proteins - Google Patents

Secreted proteins Download PDF

Info

Publication number
WO2002038602A3
WO2002038602A3 PCT/US2001/047420 US0147420W WO0238602A3 WO 2002038602 A3 WO2002038602 A3 WO 2002038602A3 US 0147420 W US0147420 W US 0147420W WO 0238602 A3 WO0238602 A3 WO 0238602A3
Authority
WO
WIPO (PCT)
Prior art keywords
secp
secreted proteins
provides
polynucleotides
agonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2001/047420
Other languages
French (fr)
Other versions
WO2002038602A2 (en
Inventor
Henry Yue
Monique G Yao
Ameena R Gandhi
Mariah R Baughn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Genomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Genomics Inc filed Critical Incyte Genomics Inc
Priority to AU2002233994A priority Critical patent/AU2002233994A1/en
Priority to JP2002541933A priority patent/JP2004534506A/en
Priority to EP01985000A priority patent/EP1341812A2/en
Priority to CA002428140A priority patent/CA2428140A1/en
Priority to US10/416,314 priority patent/US20040082508A1/en
Publication of WO2002038602A2 publication Critical patent/WO2002038602A2/en
Anticipated expiration legal-status Critical
Publication of WO2002038602A3 publication Critical patent/WO2002038602A3/en
Priority to US11/378,616 priority patent/US7608704B2/en
Priority to US12/585,371 priority patent/US8569445B2/en
Priority to US14/048,277 priority patent/US8889833B2/en
Priority to US14/480,328 priority patent/US9567383B2/en
Priority to US15/389,968 priority patent/US9914921B2/en
Priority to US15/917,537 priority patent/US20180298375A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04L—TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
    • H04L1/00—Arrangements for detecting or preventing errors in the information received
    • H04L1/12—Arrangements for detecting or preventing errors in the information received by using return channel
    • H04L1/16—Arrangements for detecting or preventing errors in the information received by using return channel in which the return channel carries supervisory signals, e.g. repetition request signals
    • H04L1/1607—Details of the supervisory signal
    • H04L1/1657—Implicit acknowledgement of correct or incorrect reception, e.g. with a moving window

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The invention provides human secreted proteins (SECP) and polynucleotides which identify and encode SECP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of SECP.
PCT/US2001/047420 2000-11-08 2001-11-08 Secreted proteins Ceased WO2002038602A2 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
AU2002233994A AU2002233994A1 (en) 2000-11-08 2001-11-08 Secreted proteins
JP2002541933A JP2004534506A (en) 2000-11-08 2001-11-08 Secreted protein
EP01985000A EP1341812A2 (en) 2000-11-08 2001-11-08 Secreted proteins
CA002428140A CA2428140A1 (en) 2000-11-08 2001-11-08 Secreted proteins
US10/416,314 US20040082508A1 (en) 2000-11-08 2001-11-08 Secreted proteins
US11/378,616 US7608704B2 (en) 2000-11-08 2006-03-20 Secreted proteins
US12/585,371 US8569445B2 (en) 2000-11-08 2009-09-14 Secreted proteins
US14/048,277 US8889833B2 (en) 2000-11-08 2013-10-08 Antibody to secreted polypeptide
US14/480,328 US9567383B2 (en) 2000-11-08 2014-09-08 Secreted proteins
US15/389,968 US9914921B2 (en) 2000-11-08 2016-12-23 Secreted proteins
US15/917,537 US20180298375A1 (en) 2000-11-08 2018-03-09 Secreted proteins

Applications Claiming Priority (12)

Application Number Priority Date Filing Date Title
US24750500P 2000-11-08 2000-11-08
US60/247,505 2000-11-08
US24964200P 2000-11-16 2000-11-16
US24982400P 2000-11-16 2000-11-16
US60/249,824 2000-11-16
US60/249,642 2000-11-16
US25282400P 2000-11-21 2000-11-21
US60/252,824 2000-11-21
US25430500P 2000-12-08 2000-12-08
US60/254,305 2000-12-08
US25644800P 2000-12-18 2000-12-18
US60/256,448 2000-12-18

Related Child Applications (4)

Application Number Title Priority Date Filing Date
US10/416,314 A-371-Of-International US20040082508A1 (en) 2000-11-08 2001-11-08 Secreted proteins
US10416314 A-371-Of-International 2001-11-08
US11/378,616 Division US7608704B2 (en) 2000-11-08 2006-03-20 Secreted proteins
US11786616 Division 2006-03-20

Publications (2)

Publication Number Publication Date
WO2002038602A2 WO2002038602A2 (en) 2002-05-16
WO2002038602A3 true WO2002038602A3 (en) 2003-06-26

Family

ID=27559348

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/047420 Ceased WO2002038602A2 (en) 2000-11-08 2001-11-08 Secreted proteins

Country Status (5)

Country Link
US (1) US20040082508A1 (en)
EP (1) EP1341812A2 (en)
AU (1) AU2002233994A1 (en)
CA (1) CA2428140A1 (en)
WO (1) WO2002038602A2 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6974684B2 (en) * 2001-08-08 2005-12-13 Curagen Corporation Therapeutic polypeptides, nucleic acids encoding same, and methods of use
US7176010B2 (en) * 2000-08-10 2007-02-13 Takeda Pharmaceutical Company Limited Isolated human protein having esterase activity and DNA encoding the same
EP1379653A2 (en) * 2000-11-01 2004-01-14 ZymoGenetics, Inc. Testis protein, zsig86
WO2002064771A1 (en) * 2001-02-15 2002-08-22 Mochida Pharmaceutical Co., Ltd. Novel cell adhesion molecule specific to activated leukocyte
EP1641821A2 (en) * 2003-06-30 2006-04-05 Genova Ltd. Human secreted proteins
ATE423140T1 (en) 2005-01-05 2009-03-15 F Star Biotech Forsch & Entw SYNTHETIC IMMUNOGLOBULIN DOMAINS WITH BINDING PROPERTIES MODIFIED IN REGIONS OF THE MOLECULE DIFFERENT FROM THE AREAS DETERMINING COMPLEMENTARITY
WO2006102072A2 (en) * 2005-03-23 2006-09-28 The Trustees Of The University Of Pennsylvania Use of a pa131 polypeptide in treatment of atherosclerosis
JP5173838B2 (en) 2006-02-13 2013-04-03 アレシア・バイオセラピューティクス・インコーポレーテッド Polynucleotide and polypeptide sequences related to the process of bone remodeling
US8168181B2 (en) 2006-02-13 2012-05-01 Alethia Biotherapeutics, Inc. Methods of impairing osteoclast differentiation using antibodies that bind siglec-15
AT503889B1 (en) 2006-07-05 2011-12-15 Star Biotechnologische Forschungs Und Entwicklungsges M B H F MULTIVALENT IMMUNE LOBULINE
PL3241842T3 (en) 2007-06-26 2024-06-10 F-Star Therapeutics Limited Display of binding agents
CN108130327A (en) 2007-10-11 2018-06-08 第三共株式会社 The antibody of targeting osteoclast-related protein Siglec-15
EP2113255A1 (en) 2008-05-02 2009-11-04 f-star Biotechnologische Forschungs- und Entwicklungsges.m.b.H. Cytotoxic immunoglobulin
EP2377932B1 (en) 2009-04-09 2020-11-18 Daiichi Sankyo Company, Limited ANTI-Siglec-15 ANTIBODY
CA2813314A1 (en) 2010-10-05 2012-04-12 Daiichi Sankyo Company, Limited Antibody targeting osteoclast-related protein siglec-15
US9464133B2 (en) 2012-03-30 2016-10-11 Daiichi Sankyo Company, Limited CDR-modified anti-Siglec-15 antibody
AU2013293062A1 (en) 2012-07-19 2014-07-24 Alethia Biotherapeutics Inc. Anti-Siglec-15 antibodies
CN122055388A (en) * 2023-11-14 2026-05-15 安菲纳治疗公司 Anti-NAPRT antibody and usage instructions

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999060020A1 (en) * 1998-05-18 1999-11-25 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
WO2000009551A1 (en) * 1998-08-10 2000-02-24 Genetics Institute, Inc. Human chordin-related proteins and polynucleotides encoding them
WO2000009552A1 (en) * 1998-08-14 2000-02-24 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
WO2001090354A1 (en) * 2000-05-20 2001-11-29 University Of Leeds Treatment of cancer and neurological diseases

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999060020A1 (en) * 1998-05-18 1999-11-25 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
WO2000009551A1 (en) * 1998-08-10 2000-02-24 Genetics Institute, Inc. Human chordin-related proteins and polynucleotides encoding them
WO2000009552A1 (en) * 1998-08-14 2000-02-24 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
WO2001090354A1 (en) * 2000-05-20 2001-11-29 University Of Leeds Treatment of cancer and neurological diseases

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BLOBEL G ET AL: "TRANSLOCATION OF PROTEINS ACROSS MEMBRANES: THE SIGNAL HYPOTHESIS AND BEYOND", SYMPOSIA OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY, COMPANY OF BIOLOGISTS, CAMBRIDGE, GB, 1979, pages 9 - 36, XP001010405, ISSN: 0081-1386 *
DATABASE EMBL [online] 20 March 2000 (2000-03-20), BIRREN B., LINTON L., NUSBAUM C., LANDER E.;: "Birren B., Linton L., Nusbaum C., Lander E.;", XP002222262, retrieved from EBI Database accession no. AC025941 *
NAGASE T ET AL: "PREDICTION OF THE CODING SEQUENCES OF UNIDENTIFIED HUMAN GENES XXI. THE COMPLETE SEQUENCES OF 60 NEW CDNA CLONES FROM BRAIN WHICH CODE FOR LARGE PROTEINS", DNA RESEARCH, UNIVERSAL ACADEMY PRESS, JP, vol. 8, no. 4, 31 August 2001 (2001-08-31), pages 179 - 187, XP001055485, ISSN: 1340-2838 *

Also Published As

Publication number Publication date
EP1341812A2 (en) 2003-09-10
AU2002233994A1 (en) 2002-05-21
US20040082508A1 (en) 2004-04-29
WO2002038602A2 (en) 2002-05-16
CA2428140A1 (en) 2002-05-16

Similar Documents

Publication Publication Date Title
WO2001098468A3 (en) Proteases
WO2000015793A3 (en) Human gpcr proteins
WO2000009709A3 (en) Proteases and associated proteins
WO2001098353A3 (en) Secreted proteins
WO2002008396A3 (en) Human proteases
WO2002048337A3 (en) Secreted human proteins
WO2003029437A3 (en) Secreted proteins
WO2001079291A3 (en) Secreted proteins
WO2002072794A3 (en) Immunoglobulin superfamily proteins
WO2003004615A3 (en) Secreted proteins
WO2002097060A3 (en) Carbohydrate-associated proteins
WO2002038744A3 (en) Proteases
WO2001071004A3 (en) Proteases
WO2002086069A3 (en) Secreted proteins
WO2002070669A3 (en) Secreted proteins
WO2001096546A3 (en) Protein phosphatases
WO2003068943A3 (en) Secreted proteins
WO2001085942A3 (en) Cytoskeleton-associated proteins
WO2002010363A3 (en) Protein phosphatases
WO2002026982A3 (en) Secreted human proteins
WO2003087300A3 (en) Secreted proteins
WO2003016506A3 (en) Secreted proteins
WO2002024924A3 (en) Protein phosphatases
WO2002020736A3 (en) Proteases
WO2001051636A3 (en) Secreted proteins

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2428140

Country of ref document: CA

Ref document number: 2002541933

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 10416314

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2001985000

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001985000

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2001985000

Country of ref document: EP